Skip to contentSkip to site index

Life science incubator Portal settles lawsuit with Beacon Capital, CalPers

Beacon Capital’s Fred Seigel, CalPERS' Marcie Frost and Portal Innovations’ Pat Flavin and John Flavin with 400 North Aberdeen Street, 135 William T Morrissey Boulevard and 7255 Helix Park Ave Suite 300

Portal Innovations reached a settlement with Beacon Capital Partners and the California Public Employees’ Retirement System, ending a legal feud that threatened the future expansion of the Chicago-based life sciences incubator.

The settlement and dismissal of the lawsuit, confirmed by Cook County court records, resolves a dispute in which Portal sued Beacon and CalPers, alleging the investors threatened to renege on commitments to provide Portal with required capital contributions. While the specific terms of the settlement agreement remain confidential, the resolution concludes a period of uncertainty that began late last year when the brawl first spilled into Cook County court.

In a statement, a spokesperson for Portal characterized the company as moving forward, asserting that “Portal’s financial position is stronger than ever.”

Still, the settlement leaves the status of several high-profile Portal projects in limbo.

Beacon didn’t return a request for comment. But its court filing in response to Portal’s allegations shed light on how expensive investments in life sciences ventures can get without much short-term return. Beacon, a major Chicago office landlord whose investments in Portal are almost fully funded by CalPers, claimed the startup accelerator’s financial performance has been “dismal,” with losses of over $50 million posted by their joint ventures.

Beacon and CalPers put $52 million into joint ventures with Portal, and Beacon also spent $42 million on various tenant buildout projects in office and lab spaces for Portal members, in buildings developed or owned by Beacon and its partners, according to Beacon court filings.

The initial legal friction raised significant questions about the viability of Portal’s planned locations in Houston, Boston and Atlanta — markets that were once central to the company’s national growth strategy. 

A Portal spokesperson declined to comment whether the settlement affects operations in those cities or if the company still intends to open additional spaces. The Boston and Houston spaces were specifically cited in the litigation as at risk without further funding from Beacon. Portal doesn’t list a Boston location on its website. The firm was set to host a grand opening of its 30,000-square-foot Houston space at a campus known as the Texas Medical Center’s Helix Park in late 2024. However, that space also isn’t listed on Portal’s website, while Beacon currently advertises its Beacon CoLab life science co-working space at the property.

Portal said in a January press release its Atlanta operation had reached more than 30 members.

With the litigation in the rearview mirror, Portal appears to be shifting its focus toward its “Powered by Portal” initiative, according to a Portal spokesperson. This managed services business aims to create partnerships with universities, governments and economic development organizations to manage lab operations and venture investing.

The company last week announced its fourth “Powered by Portal” site at Woodbine Labs in Salt Lake City, which is slated to open in the second quarter of 2027. That project joins a portfolio of managed sites that includes the recently opened University of Chicago incubator developed by Beacon and Trammell Crow in Hyde Park, as well as a New Jersey Innovation Hub, and Ocean State Labs in Rhode Island.

Beyond physical lab space, Portal is also pushing its “Stargaze Network Terminal,” an in-house digital business designed to connect its global community of entrepreneurs and investors.

For now, while Portal claims its “rapid growth” allows it to continue making investments in the companies it incubates, the map of where those companies will actually sit remains in flux.

Read more

JLL’s global life sciences chair Travis McCready
Commercial
National
Life sciences real estate hits a wall as funding dries up
Portal Innovations’ Pat Flavin and Beacon Capital’s Fred Seigel with 400 North Aberdeen Street in Chicago; 135 William T Morrissey Blvd in Dorchester; MA and 7255 Helix Park Ave Suite 300, Houston, TX
Commercial
Chicago
Deathbed for life science incubator? Portal Innovations sues partner Beacon Capital after $51M in losses
Sterling Bay Faces Default on Empty Lincoln Yards Building
Commercial
Chicago
Sterling Bay faces default on empty Lincoln Yards biotech building
Recommended For You